Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Signposts to Chiral Drugs

Organic Synthesis in Action
Buch | Hardcover
XX, 232 Seiten
2011 | 2011
Springer Basel (Verlag)
978-3-0348-0124-9 (ISBN)

Lese- und Medienproben

Signposts to Chiral Drugs - Vitomir Sunjic, Michael Parnham
CHF 224,65 inkl. MwSt
  • Versand in 10-14 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Written by authors with decades of experience in teaching and industrial research, this book details 15 chiral structures present in drug therapies and shares with readers the journey from synthetic biological reactions to subsequent medicinal applications.

Highlighting 15 selected chiral structures, which represent candidate or marketed drugs, and their chemical syntheses, the authors acquaint the reader with the fascinating achievements of synthetic and medicinal chemistry.

The book starts with an introduction treating the discovery and development of a new drug entity. Each of the 15 subsequent chapters presents one of the target structures and begins with a description of its biological profile as well as any known molecular mechanisms of action, underlining the importance of its structural and stereochemical features. This section is followed by detailed discussions of synthetic approaches to the chiral target structure, highlighting creative ideas, the scaling-up of laboratory methods and their replacement by efficient modern technologies for large-scale production. Nearly 60 synthetic reactions, most of them stereoselective, catalytic or biocatalytic, as well as chiral separating methodologies are included in the book.

Vitomir Sunjic and Michael J. Parnham provide an invaluable source of information for scientists in academia and the pharmaceutical industry who are actively engaged in the interdisciplinary development of new drugs, as well as for advanced students in chemistry and related fields.

Organic synthesis in drug discovery and development.- Aliskiren fumarate.- (R)-K-13675.- Sitagliptin phosphate monohydrate.- Biaryl unit in valsartan and vancomycin.- 3-Amino-1,4-benzodiazepines.- Sertraline.- 1,2-Dihydroquinolines.- (-)-Menthol.- Fexofenadine hydrochloride.- Montelukast sodium.- Thiolactone peptides as antibacterial peptidomimetics.- Efavirenz.- Paclitaxel.- Neoglycoconjugate.- 12-Aza

From the reviews:

"In this timely book, Sunjic and Parnham provide an exciting selection of major achievements in drug development and unfold 15 intriguing success stories of aliskiren, vancomycin, paclitaxel, menthol, efavirenz, and others from the perspective of a medicinal chemist. ... This book will be most appealing to undergraduate and graduate students with an interest in synthesis and stereochemistry ... . it should be considered an instructive teaching supplement that underscores the general significance and impact of creative synthetic chemistry and stimulates further discussion in the classroom." (Christian Wolf, Journal of the American Chemical Society, September, 2011)

"The subject of the book are chiral drugs. ... Each chapter can be read separately and consists of an abstract, introduction, the main part with the synthetic approach to a certain drug, conclusion and references. ... References are relevant and up-to date. A long list of abbreviations and acronyms is provided at the beginning ... . The book will be very useful to synthetic organic and medicinal chemists in innovative pharmaceutical companies and to scientists and ambitious students of chemistry and pharmacy." (Branka Zorc, Acta Pharmaceutica, Vol. 61, 2011)

"This ... volume will be of interest to those working in synthetic organic chemistry, particularly in the medicinal chemistry area, and having as their aim the discovery of new drug entities for the pharmaceutical industries. ... there is also a useful summary of synthetic methods and concepts that are developed in the individual chapters, together with a useful index. The standard of presentation is very high, with many clearly presented reaction schemes, and each chapter has a comprehensive list of references to the specific area." (D. W. Allen, Inflammopharmacology, Vol. 19, 2011)

Erscheint lt. Verlag 12.5.2011
Zusatzinfo XX, 232 p.
Verlagsort Basel
Sprache englisch
Maße 155 x 235 mm
Gewicht 514 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Medizin / Pharmazie Pharmazie
Medizin / Pharmazie Studium 1. Studienabschnitt (Vorklinik)
Naturwissenschaften Chemie Organische Chemie
Technik
Schlagworte chiral synthetic chemistry • chiral target structure • drug development • drug synthesis • new drug entity
ISBN-10 3-0348-0124-6 / 3034801246
ISBN-13 978-3-0348-0124-9 / 9783034801249
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Deutsche Bearbeitung der englischsprachigen Version von Ric M. …

von Stefan Bleich; Dominik Dabbert; Stefan Kropp …

Buch | Softcover (2022)
Hogrefe Verlag
CHF 113,95